I hadn't realized that the title was so specific as “drugs for rare diseases”. I think a number of the witnesses will be talking about the need for radiopharmaceuticals. So it is a round table on the treatment of rare diseases and access for persons with rare diseases.
On June 1st, 2010. See this statement in context.